Free Trial

BrainsWay (BWAY) Stock Forecast & Price Target

$6.61
-0.07 (-1.05%)
(As of 07/17/2024 ET)

BrainsWay - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 3 Wall Street analysts who have issued ratings for BrainsWay in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for BWAY.

Consensus Price Target

$13.00
96.67% Upside
High Forecast$15.00
Average Forecast$13.00
Low Forecast$11.00

According to the 3 analysts' twelve-month price targets for BrainsWay, the average price target is $13.00. The highest price target for BWAY is $15.00, while the lowest price target for BWAY is $11.00. The average price target represents a forecasted upside of 96.67% from the current price of $6.61.

TypeCurrent Forecast
7/19/23 to 7/18/24
1 Month Ago
6/19/23 to 6/18/24
3 Months Ago
4/20/23 to 4/19/24
1 Year Ago
7/19/22 to 7/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.00$13.00$7.00$6.67
Forecasted Upside96.67% Upside107.50% Upside86.73% Upside257.62% Upside
Get BrainsWay Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.

BWAY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BWAY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BrainsWay Stock vs. The Competition

TypeBrainsWayMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.71
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside96.67% Upside1,213.02% Upside7.87% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/5/2024HC Wainwright
3 of 5 stars
B. Pachaiyappan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00+118.02%
5/9/2024Oppenheimer
3 of 5 stars
 Boost TargetOutperform ➝ Outperform$10.00 ➝ $11.00+94.69%
11/16/2023Raymond James
4 of 5 stars
 DowngradeOutperform ➝ Market Perform
11/17/2022Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$15.00 ➝ $5.00+128.31%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 04:17 AM ET.

BWAY Forecast - Frequently Asked Questions

What is BrainsWay's forecast for 2024?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for BrainsWay is $13.00, with a high forecast of $15.00 and a low forecast of $11.00.

Should I buy or sell BrainsWay stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last twelve months. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" BWAY shares.

Does BrainsWay's stock price have much upside?

According to analysts, BrainsWay's stock has a predicted upside of 107.50% based on their 12-month stock forecasts.

What analysts cover BrainsWay?

BrainsWay has been rated by research analysts at HC Wainwright, and Oppenheimer in the past 90 days.

Do Wall Street analysts like BrainsWay more than its competitors?

Analysts like BrainsWay less than other "medical" companies. The consensus rating score for BrainsWay is 2.67 while the average consensus rating score for "medical" companies is 2.72. Learn more on how BWAY compares to other companies.


This page (NASDAQ:BWAY) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners